Aflibercept inhibits tumor growth more effectively than bevacizumab in patient-derived xenograft (PDX) models of colorectal cancer

被引：0
|
作者：
Chiron, M. [1 ]
Bagley, R. G. [2 ]
Pollard, J. R. [3 ]
Henry, C. [4 ]
Mankoo, P. K. [3 ]
Vincent, L. [5 ]
Geslin, C. [4 ]
Amalou, Z. [6 ]
Baltes, N. [6 ]
Bergstrom, D. A. [3 ]
机构：
[1] Sanofi Oncol, Translat & Expt Med, Vitry Sur Seine, France
[2] Sanofi Oncol, Clin Dev, Cambridge, MA USA
[3] Sanofi Oncol, Translat & Expt Med, Cambridge, MA USA
[4] Sanofi Oncol, Oncol, Vitry Sur Seine, France
[5] Sanofi Oncol, Pharmacol, Vitry Sur Seine, France
[6] Oncotest GmbH, Project Management, Freiburg, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2201
引用
收藏
页码：S497 / S498
页数：2
相关论文
共 50 条
  • [1] Differential Antitumor Activity of Aflibercept and Bevacizumab in Patient-Derived Xenograft Models of Colorectal Cancer
    Chiron, Marielle
    Bagley, Rebecca G.
    Pollard, Jack
    Mankoo, Parminder K.
    Henry, Christophe
    Vincent, Loic
    Geslin, Catherine
    Baltes, Nina
    Bergstrom, Donald A.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2014, 13 (06) : 1636 - 1644
  • [2] Switching to aflibercept treatment resulted in greater tumor responses than continuous bevacizumab treatment in patient-derived xenograft models of colorectal cancer.
    Chiron, Marielle
    Bagley, Rebecca G.
    Pollard, Jack
    Henry, Christophe
    Mankoo, Parminder
    Vincent, Loic
    Geslin, Catherine
    Kloss, Tatjana
    Bergstrom, Donald A.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [3] Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models
    Prasetyanti, Pramudita R.
    van Hooff, Ander R.
    van Herwaarden, Tessa
    de Vries, Nathalie
    Kalloe, Kieshen
    Rodermond, Hans
    van Leersum, Ronald
    de Jong, Joan H.
    Franitza, Marek
    Nuernberg, Peter
    Todaro, Matilde
    Stassi, Giorgio
    Medema, Jan Paul
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (02) : 366 - 371
  • [4] Exercise inhibits tumor growth and central carbon metabolism in patient-derived xenograft models of colorectal cancer
    Min Lu
    Sydney M Sanderson
    Amelia Zessin
    Kathleen A Ashcraft
    Lee W Jones
    Mark W Dewhirst
    Jason W Locasale
    David S Hsu
    [J]. Cancer & Metabolism, 6
  • [5] Exercise inhibits tumor growth and central carbon metabolism in patient-derived xenograft models of colorectal cancer
    Lu, Min
    Sanderson, Sydney M.
    Zessin, Amelia
    Ashcraft, Kathleen A.
    Jones, Lee W.
    Dewhirst, Mark W.
    Locasale, Jason W.
    Hsu, David S.
    [J]. CANCER & METABOLISM, 2018, 6
  • [6] UTILIZATION OF PATIENT-DERIVED TUMOR XENOGRAFT (PDX) MODELS IN ONCOLOGY
    Cybula, Magdalena
    Moxley, Katherine
    Wang, Lin
    Wang, Luyao
    Bieniasz, Magdalena
    [J]. CLINICAL CANCER RESEARCH, 2019, 25 (22) : 84 - 84
  • [7] Olaparib Inhibits Tumor Growth of Hepatoblastoma in Patient-Derived Xenograft Models
    Johnston, Michael Edward, II
    Rivas, Maria Prates
    Nicolle, Delphine
    Gorse, Aurore
    Gulati, Ruhi
    Kumbaji, Meenasri
    Weirauch, Matthew T.
    Bondoc, Alexander
    Cairo, Stefano
    Geller, James
    Tiao, Gregory
    Timchenko, Nikolai
    [J]. HEPATOLOGY, 2021, 74 (04) : 2201 - 2215
  • [8] Patient-derived xenograft (PDX) models, applications and challenges in cancer research
    Abdolahi, Shahrokh
    Ghazvinian, Zeinab
    Muhammadnejad, Samad
    Saleh, Mahshid
    Asadzadeh Aghdaei, Hamid
    Baghaei, Kaveh
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [9] Patient-derived xenograft (PDX) models, applications and challenges in cancer research
    Shahrokh Abdolahi
    Zeinab Ghazvinian
    Samad Muhammadnejad
    Mahshid Saleh
    Hamid Asadzadeh Aghdaei
    Kaveh Baghaei
    [J]. Journal of Translational Medicine, 20
  • [10] PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models
    Meehan, Terrence F.
    Conte, Nathalie
    Goldstein, Theodore
    Inghirami, Giorgio
    Murakami, Mark A.
    Brabetz, Sebastian
    Gu, Zhiping
    Wiser, Jeffrey A.
    Dunn, Patrick
    Begley, Dale A.
    Krupke, Debra M.
    Bertotti, Andrea
    Bruna, Alejandra
    Brush, Matthew H.
    Byrne, Annette T.
    Caldas, Carlos
    Christie, Amanda L.
    Clark, Dominic A.
    Dowst, Heidi
    Dry, Jonathan R.
    Doroshow, James H.
    Duchamp, Olivier
    Evrard, Yvonne A.
    Ferretti, Stephane
    Frese, Kristopher K.
    Goodwin, Neal C.
    Greenawalt, Danielle
    Haendel, Melissa A.
    Hermans, Els
    Houghton, Peter J.
    Jonkers, Jos
    Kemper, Kristel
    Khor, Tin O.
    Lewis, Michael T.
    Lloyd, K. C. Kent
    Mason, Jeremy
    Medico, Enzo
    Neuhauser, Steven B.
    Olson, James M.
    Peeper, Daniel S.
    Rueda, Oscar M.
    Seong, Je Kyung
    Trusolino, Livio
    Vinolo, Emilie
    Wechsler-Reya, Robert J.
    Weinstock, David M.
    Welm, Alana
    Weroha, S. John
    Amant, Frederic
    Pfister, Stefan M.
    [J]. CANCER RESEARCH, 2017, 77 (21) : E62 - E66
12345